Latest news
Loading news…
Beam Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2017 501-1000 employees For Profit
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
512
Ticker
BEAM
NASDAQ
Patents
121
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- BEAM
- Exchange
- NASDAQ
- IPO date
- Feb 6, 2020
- Raised at IPO
- $207M
- Valuation at IPO
- $843M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 22
- Patents granted
- 121
- Trademarks
- 6
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $4M
Company Info
- Founded
- 2017
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- Sub-organizations
- 1
- News articles
- 252
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Feb 6, 2020
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- -0.5
- Trend (90d)
- -0.8
- Last leadership hire
- Dec 19, 2024
- Last layoff mention
- Oct 19, 2023
Acquisitions by Beam Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Beam Therapeutics
CEO
Chief Scientific Officer & President
Chief Financial Officer
Director, Alliance Management & Business Development
Sr. Director, Product Quality Lead; Cell Therapy
Associate Director, Strategy and Competitive Intelligence
Chief Legal Officer
Senior Director, Head of Gene Editing Platform Technologies
512
professional contacts at Beam Therapeutics
Contact execs at Beam Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Beam Therapeutics
Loading news…
FAQs about Beam Therapeutics
People who checked this page also checked these
Sectors Beam Therapeutics invests & acquires in
Browse the full Acquirezy directory.